Alpelisib

Brand name: Piqray

Rank #466 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$15.7M

Total Cost

Share:

747

Total Claims

$15.7M

Total Cost

54

Prescribers

$21K

Cost per Claim

0

Beneficiaries

757

30-Day Fills

$291K

Avg Cost/Provider

14

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$15.7M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $15.7M total

🔎 Data Overview

💰

At $21,070 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $291,467 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Alpelisib

#ProviderSpecialtyLocationClaimsCost
1Eva ThomasHematology-OncologyOakland, CA24$532K
2John CharlsonMedical OncologyMilwaukee, WI15$515K
3Melanie ClarkHematology-OncologyFort Wayne, IN20$446K
4Rekha KumblaHematologyKennesaw, GA19$432K
5Joseph ShatzelHematology-OncologyPortland, OR12$405K
6Gregory GilmoreHematology-OncologyCorona, CA18$385K
7Ali AmeriInternal MedicineNew York, NY17$381K
8Shanti ThomasMedical OncologyBrownstown Twp, MI18$380K
9David AdkinsHematology-OncologyModesto, CA18$371K
10Kim GococoHematology-OncologyGreenville, SC16$352K
11Vita Saranga-PerryHematology-OncologyPlant City, FL15$331K
12Hatem SolimanHematology-OncologyTampa, FL16$331K
13Lucille AlstonHematology-OncologyOgdensburg, NY15$330K
14Saqib RazzaqueInternal MedicineEl Centro, CA15$315K
15Amrit Paul BainsPharmacistRoseville, CA14$312K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
463Leflunomide (Leflunomide)$16.0M205,765
464Hydrocortisone (Hydrocortisone)$15.9M762,398
465Digoxin (Digoxin)$15.9M548,410
466Alpelisib (Piqray)$15.7M747
467Doxazosin Mesylate (Doxazosin Mesylate)$15.7M729,878
468Prucalopride Succinate (Motegrity)$15.7M22,068
469Ketorolac Tromethamine (Ketorolac Tromethamine)$15.6M582,750

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology